Parameters of mineral metabolism predict midterm clinical outcome in end-stage heart failure patients

Scandinavian Cardiovascular Journal

Volumn 45, Issue 6, 2011, Pages 342-348

  Zittermann, Armin ^a   Fuchs, Uwe ^a   Kuhn, Joachim ^a   Dreier, Jens ^a   Schulz, Uwe ^a   Gummert, Jan F ^a   Börgermann, Jochen ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

1,25 dihydroxyvitamin D; cardiac transplantation; fibroblast growth factor 23; mechanical circulatory support; mortality; survival

Indexed keywords

CALCITRIOL; FIBROBLAST GROWTH FACTOR 23; MAGNESIUM ION; PARATHYROID HORMONE; SODIUM ION;

ADULT; ARTICLE; ASSISTED CIRCULATION; CALCIUM METABOLISM; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; MAGNESIUM BLOOD LEVEL; MAGNESIUM METABOLISM; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE METABOLISM; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SODIUM METABOLISM;

BIOLOGICAL MARKERS; DISEASE-FREE SURVIVAL; FEMALE; FIBROBLAST GROWTH FACTORS; GERMANY; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MAGNESIUM; MALE; METABOLIC DISEASES; MIDDLE AGED; PARATHYROID HORMONE; PILOT PROJECTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SODIUM; TIME FACTORS; VITAMIN D;

EID: 81055133457     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017431.2011.611250     Document Type: Article

References (28)

1. Califf RM, Adams KF, McKenna WJ, Gheorghiade M, Uretsky BF, McNulty SE, et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J 1997;134:44-54 . (Pubitemid 27329022)
2. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001;345:1435-43 .
3. Copeland JG, Smith RG, Arabia FA, Nolan PE, Sethi GK, Tsau PH, et al. CardioWest Total Artifi cial Heart Investigators. CardioWest Total Artifi cial Heart Investigators. Cardiac replacement with a total artifi cial heart as a bridge to transplantation. N Engl J Med 2004; 351:859-67 . (Pubitemid 39099324)
4. Goldstein DJ, Smego D, Michler RE. Surgical aspects of congestive heart failure. Heart Fail Rev 2006;11:171-192 (Pubitemid 44288732)
5. Nicolini F, Gherli T. Alternatives to transplantation in the surgical therapy for heart failure. Eur J Cardiothorac Surg 2009;35:214-28 .
6. Sica DA. Hyponatremia and heart failure-treatment considerations. Congest Heart Fail 2006;12:55-60 .
7. Milionis HJ, Alexandrides GE, Liberopoulos EN, Bairaktari ET, Goudevenos J, Elisaf MS. Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure. Eur J Heart Fail 2002;4: 167-73 . (Pubitemid 34233503)
8. Zittermann A, Schleithoff SS, Koerfer R: Vitamin D insuffi ciency in congestive heart failure: Why and what to do about it? Heart Fail Rev 2006;11:25-33 . (Pubitemid 43986205)
9. Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, K ö rfer R, Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 2003;41:105-12 . (Pubitemid 36044411)
10. Pilz S, MÄ r z W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, et al. Association of vitamin D defi ciency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008;93:3927-35 .
11. Zittermann A, Schleithoff SS, Gö t ting C, Fuchs U, Kuhn J, Kleesiek K, et al. Calcitriol defi ciency and 1-year mortality in cardiac transplant recipients. Transplantation 2009;87: 118-24 .
12. Antoniucci DM, Yamashita T, Portale AA. Dietary phosphorus regulates serum fi broblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 2006;91: 3144-9 . (Pubitemid 44271770)
13. Kirkpantur A, Balci M, Gurbuz OA, Afsar B, Canbakan B, Akdemir R, et al. Serum fi broblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients. Nephrol Dial Transplant 2011;26:1346-54.
14. Guti é rrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008;359:584-92 .
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular fi ltration rate from serum creatinine: a new prediction equation. Modifi cation of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-70 . (Pubitemid 29135798)
16. Weber KT, Weglicki WB, Simpson RU. Macro- and micronutrient dyshomeostasis in the adverse structural remodeling of myocardium. Cardiovasc Res 2009;81:500-8 .
17. Hoppe J-D, Schreiber H-L. Richtlinien zur Organtransplantation gem Ä ß § 16 Transplantationsgesetz. Dtsch Arztebl 2000;97:A-396-A-411 .
18. Altura BT, Wilimzig C, Trnovec T, Nyulassy S, Altura BM. Comparative effects of a Mg-enriched diet and different orally administered magnesium oxide preparations on ionized Mg, Mg metabolism and electrolytes in serum of human volunteers. J Am Coll Nutr 1994;13:447-54 . (Pubitemid 24309976)
19. Weglicki WB, Phillips TM. Pathobiology of magnesium defi - ciency: a cytokine/neurogenic infl ammation hypothesis. Am J Physiol 1992;263:R734-R737 .
20. Zittermann A, Gummert JF. Nonclassical vitamin D actions. Nutrients 2010;2:408-25 .
21. Kalantar-Zadeh K, Shah A, Duong U, Hechter RC, Dukkipati R, Kovesdy CP. Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl 2010;78:S10-S21 .
22. Bj ör kman MP, Sorva AJ, Risteli J, Tilvis RS. Low parathyroid hormone levels in bedridden geriatric patients with vitamin D defi ciency. J Am Geriatr Soc 2009;57:1045-50 .
23. Ogino K, Burkhoff D, Bilezikian JP. The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology 1995;136:3024-30 .
24. Moorthi RN, Kandula P, Moe SM. Optimal vitamin D, calcitriol, and vitamin D analog replacement in chronic kidney disease: to D or not to D: that is the question. Curr Opin Nephrol Hypertens. 2011;20:354-59 .
25. Cohen N, Golik A. Zinc balance and medications commonly used in the management of heart failure. Heart Fail Rev 2006;11:19-24 . (Pubitemid 43994885)
26. Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, et al. Anemia and mortality in heart failure patients a systematic review and metaanalysis. J Am Coll Cardiol 2008;52:818-27 .
27. Spertus JA, Jones P, McDonell M, Fan V, Fihn SD. Health status predicts long-term outcome in outpatients with coronary disease. Circulation 2002;106:43-9 . (Pubitemid 34747440)
28. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classifi cation system. Crit Care Med. 1985;13:818-29. (Pubitemid 15250137)